CCL2 and systemic lupus erythematosus: Altogether, our data suggested a model whereby restoring lymphatic flow in UVR-treated SLE mice reduces draining lymph node B cell responses at least in part by upregulating stromal CCL2 and increasing monocyte ROS to limit plasmablast accumulation.